A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
A weekly GLP-1 and GIP dual agonist from Viking Therapeutics, the same two-receptor approach as tirzepatide, also being tested as a daily tablet. In its 13-week phase 2 trial, people lost about 9% to 15% of their body weight depending on the dose, with no sign of levelling off. Commonly reported: in trials, nausea and other GI effects early on, fading as the dose holds. It is in phase 3 and not approved anywhere.
With a 10 mg vial and 2 mL of water (5 mg in every mL), on a 1 mL (100-unit) U-100 insulin syringe: the low end, 2.5 mg, is 50 units; and the high end, 17.5 mg, needs more than this vial holds. 4 doses in the vial at the low end. All U-100: 100 units to the mL. A U-40 syringe reads differently.
VK2735 in the peptide libraryThe Dose Guide: every peptide
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.
PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.
Get PepVault on the App Store7 days free on the yearly plan for new subscribers.
A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.
Newsletter · Weekly
New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.